Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over prasugreL: a mUlticenter Randomized Open-label Trial in patientS With ST-elevation Myocardial inFarction Referred for primAry percutaneouS inTERvention.FABOLUS FASTER Trial

Trial Profile

Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over prasugreL: a mUlticenter Randomized Open-label Trial in patientS With ST-elevation Myocardial inFarction Referred for primAry percutaneouS inTERvention.FABOLUS FASTER Trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Cangrelor (Primary) ; Prasugrel (Primary) ; Tirofiban (Primary)
  • Indications Coronary artery disease; Myocardial infarction
  • Focus Pharmacodynamics
  • Acronyms FABOLUS-FASTER
  • Most Recent Events

    • 18 Sep 2017 Planned End Date changed from 1 Apr 2018 to 1 Jul 2018.
    • 18 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Jul 2018.
    • 18 Sep 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top